Cargando…
The stress of coping with E2F loss
E2F transcription factors are key regulators of cellular proliferation, and altered E2F activity is a common feature of tumor cells. Thus, E2F targeting is being explored as a therapeutic strategy in cancer. Importantly, recent mouse knockout studies show that concomitant loss of E2f1/E2f2 activity...
Autores principales: | Iglesias-Ara, Ainhoa, Zubiaga, Ana M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4845195/ https://www.ncbi.nlm.nih.gov/pubmed/27308555 http://dx.doi.org/10.1080/23723556.2015.1038423 |
Ejemplares similares
-
Targeting E2F Sensitizes Prostate Cancer Cells to Drug-Induced Replication Stress by Promoting Unscheduled CDK1 Activity
por: Hamidi, Mohaddase, et al.
Publicado: (2022) -
Control of S phase duration: a replication capacity model with E2F transcription at its heart
por: Bertoli, Cosetta, et al.
Publicado: (2021) -
E2f2 Attenuates Apoptosis of Activated T Lymphocytes and Protects from Immune-Mediated Injury through Repression of Fas and FasL
por: Mustafa, Noor, et al.
Publicado: (2021) -
Rethinking the role of myeloid-derived suppressor cells in adoptive T-cell therapy for cancer
por: Arina, Ainhoa
Publicado: (2014) -
AMBRA1-induced mitophagy: A new mechanism to cope with cancer?
por: Strappazzon, Flavie, et al.
Publicado: (2015)